Target intelligence / Profile preview

Poly(A) binding protein cytoplasmic 1 pseudogene 2 (PABPC1P2)

Target
PABPC1P2
Molecular classification
Other (Pseudogene), Poly(A) binding protein family member (nonfunctional)
01

Overview

Poly(A) binding protein cytoplasmic 1 pseudogene 2 (PABPC1P2) is a noncoding pseudogene in humans, classified as a member of the poly(A) binding protein family but lacking evidence of protein-coding ability and functional protein product. The name suggests similarity to poly(A) binding proteins involved in mRNA stabilization, translation, and post-transcriptional regulation, but PABPC1P2 itself does not perform these functions. It is often listed alongside the aliases PABP2 and PABP4, which refer to functional poly(A) binding proteins—such as PABPC4 (involved in erythroid cell development) and PABPN1 (polyadenylate-binding nuclear protein 1 associated with mRNA processing and oculopharyngeal muscular dystrophy)—but PABPC1P2 should not be confused with these. Pseudogenes like PABPC1P2 are generally not considered direct therapeutic targets, though some may exert regulatory roles by acting as microRNA decoys or influencing gene expression indirectly in limited contexts.

Other names
PABP2PABP4PABPCP2PABPCP4
02

Mechanism of action

None applicable, since the gene does not encode a functional protein.

03

Biological functions

None directly for this gene, as it does not encode a functional protein; pseudogenes can have regulatory functions through noncoding RNA in rare cases, but specific function for PABPC1P2 is not established
04

Disease associations

None directly. PABPC1P2 is not implicated in disease pathology as a functional protein.

Beyond the preview

Go deeper on Poly(A) binding protein cytoplasmic 1 pseudogene 2 (PABPC1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Poly(A) binding protein cytoplasmic 1 pseudogene 2 (PABPC1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call